Leerink Partners Starts Crinetics (CRNX) at Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Leerink Partners Starts Crinetics (CRNX) at Outperform

Piper Jaffray Starts Crinetics (CRNX) at Overweight

August 13, 2018 4:06 AM EDT

Piper Jaffray analyst Tyler Van Buren initiates coverage on Crinetics (NASDAQ: CRNX) with a Overweight rating and a price target of $40.00.

Van Buren believes CRN02481 has significant potential due to the lack of available treatment options and has a high level of... More

JPMorgan Starts Crinetics (CRNX) at Neutral

August 13, 2018 1:21 AM EDT

JPMorgan analyst Jessica Fye initiates coverage on Crinetics (NASDAQ: CRNX) with a Neutral rating and a price target of $29.00.

Fye sees upside for the company over time as the company generates data supporting efficacy and safety in patients along with Phase 1 data for... More